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Abstract 25 
During early pregnancy, the human uterus undergoes profound tissue remodeling characterized by 26 
leukocyte invasion and production of proinflammatory cytokines, followed by tissue repair and 27 
tolerance maintenance induction. Vasoactive intestinal peptide (VIP) is produced by trophoblast cells 28 
and modulates the maternal immune response towards a tolerogenic profile. Here, we evaluated the 29 
VIP/VPAC system contribution to endometrial renewal, inducing decidualization and the recruitment of 30 
induced regulatory T cells (iTregs) that accompany the implantation period. For that purpose, we used 31 
an in vitro model of decidualization with a human endometrial stromal cell line (HESC) stimulated with 32 
progesterone and LPS (Lipopolysaccharide) simulating the inflammatory response during implantation 33 
and human iTregs (CD4+CD25+FOXP3+) cells differentiated from naïve T cells obtained from fertile 34 
women peripheral blood monuclear cells. 35 
We observed that VIP and its receptor VPAC1 are constitutively expressed in HESC cells and 36 
progesterone increased VIP expression. Moreover, VIP induced RANTES expression by HESC, one of 37 
the main chemokines involved in T cell-recruitment and this effect is enhanced by the presence of 38 
progesterone and LPS. Finally, migration assays of iTregs toward conditioned media from HESC cells 39 
revealed that endogenous VIP production induced by P4 and LPS and RANTES production were 40 
involved since the anti-RANTES neutralizing Ab or VIP antagonist prevented their migration. We 41 
conclude that VIP may have an active role in the decidualization process thus contributing to iTregs 42 
recruitment toward endometrial stromal cells by increasing RANTES expression in a progesterone-43 
dependent manner.  44 
 45 
46 
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INTRODUCTION  47 
Endometrial receptivity, embryo implantation and the maintenance of pregnancy is a sequence of 48 
intricate events that requires a coordinated interaction between the endometrial epithelial and stromal 49 
cells, the maternal immune system, and the blastocyst (Dey et al. 2004, Stoikos et al. 2008, Gellerson et 50 
al. 2007).  51 
In this context, the early pregnant uterus undergoes profound remodeling and leukocyte invasion 52 
associated with the production of proinflammatory factors (Pérez Leirós & Ramhorst 2013, Dimitriadis 53 
et al. 2005) . Under the influence of progesterone, endometrial stromal cells differentiate into epithelioid 54 
decidual cells and secrete diverse mediators, which contribute to the generation of a local immune 55 
privileged site supporting the nidation of a semiallogenic fetus (Gellerson et al.  2003, Mesiano  et al. 56 
2011).  57 
The decidualization of the stromal cells also occurs in the absence of pregnancy and the declining 58 
progesterone levels trigger several effects, such as the expression of proinflammatory cytokines, 59 
chemokines and matrix metalloproteinases, and activate a sequence of events leading to menstruation 60 
(Salomonsen et al. 1999, Catalano et al. 2007). Moreover, decidualization in humans is apparent 10 61 
days after ovulation, indicating that progesterone is not the primary trigger of this differentiation 62 
process. In fact, initiation of the decidual process is dependent on elevated levels of cAMP (Teklenburg  63 
et al. 2010a), suggesting that local factors could be involved in the activation of adenylate cyclase in 64 
stromal cells. 65 
Since menstruation and early pregnancy are inflammatory conditions that cause a degree of 66 
physiological tissue injury, the exposure of the uterus to a threatening stimulus at a dose below the 67 
threshold for tissue injury will provide tolerance against a more severe subsequent insult (Teklenburg  et 68 
al. 2010b, King et al. 2010).   69 
During the process of tissue renewal associated with the menstrual cycle, uterine cells undergo 70 
apoptosis necessary for the removal of cellular debris. Implantation and early placentation represent still 71 
another period of high tissue turnover and renewal. During the early stage of implantation, trophoblast 72 
cells break the epithelial lining of the uterus in order to adhere, then invade endometrial tissue and 73 
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replace endothelial cells, generating apoptotic bodies of trophoblast that will contribute to the induction 74 
of a tolerogenic microenvoirenment (Abrahams et al. 2004a). Therefore implantation involves a tight 75 
homeostatic control provided by immune cells selectively recruited and/or expanded depending on the 76 
subpopulation during early stages of gestation and the contribution of redundant molecules able to 77 
trigger multiple tolerogenic programs ((Pérez Leirós & Ramhorst 2013, Gomez-Lopez et al. 2010).  In 78 
this context, the modulation of chemokines and their receptors selectively controls the recruitment of di-79 
fferent leukocyte populations (Bromley et al. 2008, Fraccaroli et al. 2009a). During the implantation 80 
period, in particular, the β-chemokine CCL5 (RANTES) is locally produced by the human endometrium 81 
and, interestingly, it has the potential to act in an autocrine manner by the differential expression of its 82 
receptors CCR1, CCR3, and CCR5 (Ramhorst et al. 2006, Ramhorst et al. 2008). In addition, RANTES 83 
is produced by human endometrial T-lymphocytes, CD4+ and CD8+, and its production is increased in 84 
the presence of physiological progesterone concentrations (Ramhorst et al. 2006).  85 
One of the main effects of RANTES is the induction and the recruitment of regulatory T cells 86 
(Tregs) (Fraccaroli et al.  2009b). The specialized Tregs population is essential for preventing a 87 
maternal immune response against paternal antigens. Basically, natural Tregs (nTregs) (derived from the 88 
thymus) that constitutively express CD25 can be distinguished from inducible Tregs, CD4+CD25+ 89 
FOXP3+ cells that are induced from CD4+CD25- precursors in the peripheral lymphoid organs (iTregs) 90 
(Guerin et al. 2009). Prior to implantation the seminal fluid can drive iTregs expansion (Robertson et al. 91 
2009). and then the continuous release of placental antigens into the maternal circulation would 92 
maintain a Treg population targeted specifically against paternal antigens (Aluvihare et al. 2004). 93 
Previously, we described the development of an in vitro differentiation model of iTregs from naïve 94 
CD45RA+CCR7+ obtained from peripheral blood mononuclear cells isolated from fertile women. We 95 
observed that trophoblast cells not only contributed to their differentiation in a TGF-β dependent 96 
pathway, but also secreted chemokines, such as RANTES, MCP-1, and IL-8, which were capable of 97 
selectively recruiting them (Ramhorst et al. 2012).  98 
 VIP is a pleiotropic peptide with embryotrophic, smooth muscle relaxing, prosecretory and 99 
immunomodulatory effects (Ekstrom et al. 1983, Spong et al. 1999, Covineau et al. 2012, Leceta et al. 100 
2007, Gonzalez-Rey et al. 2007). VIP was shown to down-regulate inflammatory factors and inhibit 101 
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antigen specific Th1-driven immune responses switching to a tolerogenic profile with the generation or 102 
expansion of Treg cells (Leceta et al. 2007, Gonzalez-Rey et al. 2007). In addition, among several 103 
mediators released locally, we have proposed a role of VIP at the early maternal-placental interface with 104 
immunosuppressant and trophic effects (Perez Leiros & Ramhorst 2013, Fraccaroli et al. et al. 2009c). 105 
Certainly, using an in vitro model of trophoblast and maternal leukocyte interaction, VIP showed a Th1-106 
limiting and Treg-promoting response that would favor early pregnancy outcome. VIP also decreased 107 
the production of inflammatory mediators after culturing fertile women-PBMCs with trophoblast cells; 108 
while it increased TFGβ and IL-10 production (Fraccaroli et al. et al. 2009). 109 
Taking into account that endometrial stromal cells are exposed to an inflammatory response that 110 
preconditions the uterus at peri implantation period and that VIP mediates pro-tolerogenic responses, we 111 
evaluated the contribution of VIP/VPAC system to endometrial renewal, inducing decidualization and 112 
the recruitment of iTregs that accompany the implantation period. In the present study we used an in 113 
vitro model of decidualization with a human endometrial stromal cell line (HESC) stimulated with 114 
progesterone and LPS simulating the inflammatory response during implantation. 115 
 116 
Materials and Methods 117 
Human Endometrial Stromal Cells (HESC)   118 
Immortalized Human Endometrial Stromal cell line HESC described by Krikun et al. were maintained 119 
in DMEM-F12 supplemented with 10% FCS and 2mM glutamine (Krikun et al. 2004). For the different 120 
assays, HESC cells were cultured in 24-well plates until they reached 70% confluence. Different 121 
combinations of VIP (10
-7
M), LPS (100 ng/ml), Progesterone (P4, 10
-6
M, the physiologic concentration 122 
reported at the feto-maternal interface (31) and VIP-antagonist (ANT, 10-5M) were added for 24 h.  123 
Conditioned media (CM):  HESC cells were cultured in DMEM-F12 10% FCS and overnight 124 
supernants were collected and maintained at -20°C until use.  125 
Decidualization: HESC cells were cultured in 24 wells-plate with DMEM-F12 10% FCS in the 126 
presence of VIP (10
-6
M-10
-8
M) o medroxiprogesterone MPA (10
-8
M)- dibutyryl cAMP (2,5 10
-3
M) for 127 
8 days, changing half of the culture media every 48 hours and then used in the assays described below. 128 
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 129 
Peripheral Blood Mononuclear Cells (PBMCs)  130 
PBMCs were isolated from fertile, non-pregnant women who had two or more previous normal 131 
pregnancies without any miscarriage. The “Investigation and Ethics Committee” from the 132 
Argentinean Society of Gynecological and Reproductive Endocrinology (SAEGRE) has approved this 133 
study and all the patients provided their written consent to participate in it.  134 
PBMCs were isolated from heparinized peripheral blood by a density gradient centrifugation on 135 
Ficoll-Hypaque (Amersham Pharmacia Biotech, Uppsala, Sweden). Cells were extensively washed 136 
and resuspended in RPMI 1640 (Life Technologies Grand Island, NY) supplemented with 10% human 137 
AB serum, 2mM glutamine and 1% penicillin-streptomycin.  138 
 139 
In vitro differentiation of iTregs 140 
In vitro differentiation was performed as previously described (Ramhorst et al. 2012). Briefly, naïve 141 
CD4 T cells were isolated from fertile women-PBMCs by negative depletion using the Easy Sep Kit 142 
and following manufacturer recommendations. The recovered naïve CD4 T cells were cultured in 143 
precoated plates with anti-CD3 (10 µg/ml, BD-Pharmigen, Franklin Lakes, NJ, USA) + anti-CD28 (1 144 
µg/ml, BD-Pharmigen, Franklin Lakes, NJ, USA) and maintained with media supplemented with IL-2 145 
(2 ng/ml, Peprotech, USA) and recombinant TGFβ (10 ng/ml, R&D System, MN, USA). Media was 146 
changed every 48 hours and after 5 days of culture we obtained 26±4% of CD4+FOXP3+ cells.  147 
 148 
Real Time PCR 149 
We evaluated the chemokines IL-8, MCP-1 and RANTES as well as VIP and its receptors VPAC1 and 150 
VPAC2, and decidualization markers KLF13 and IGFBP1 expression in HESC cells under different 151 
stimuli combinations. After 24 hours of stimulation, total RNA was isolated following manufacturer 152 
recommendations with Trizol reagent (Life Technologies, Grand Island, NY, USA), cDNAs were 153 
generated from 1µg or RNA using a MMLV reverse transcriptase, RNAsin RNAse inhibitor and oligo 154 
(dT) kit (Clontech; Palo Alto, CA, USA) and stored at -20°C for batch analysis. Sample volume was 155 
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increased to 25 µl with the solution containing 50 mM KCl; 10mM Tris (pH 8.3); 1.5 mM MgCl2; 0.1 156 
µM forward and reverse primers (described in Table I), 1 U Taq polymerase in a DNA Thermocycler 157 
(PerkinElmer/Cetus, Boston, MA, USA) and 1:30000 dilution of SybrGreen. The PCR programs used 158 
were an initial denaturalization at 95˚C for 5min, followed by 35 cycles of 95˚C for 20sec, 20sec at 159 
melting temperature specified in Table  I and 20sec at 72˚C. SybrGreen fluorescence was measure at 160 
the end of each cycle. A final elongation at 72˚C for 10 min was also performed. Realtime PCR was 161 
performed on a Bio-Rad iQ5 Realtime PCR system. Results were expressed as arbitrary units 162 
normalized to GAPDH expression. 163 
Flow-cytometry analysis  164 
Intracellular staining for FOXP3 detection 165 
The flow cytometric analysis was performed according to the manufacturer’s instructions (Human 166 
Regulatory T cell staining kit, eBioscience, San Diego, CA). After migration, cells were recovered from 167 
the lower compartment, washed and then incubated with the fixation/permeabilization buffer for 1 hour. 168 
After washing, unspecific sites were blocked by adding 2 µl (2% final) normal rat serum, in 169 
approximately 100 µl for 15 min. Then cells were incubated with the anti-human FOXP3 (PCH101) 170 
antibody or rat IgG2a isotype control for at least 30 min at 4ºC. Finally, cells were washed with 171 
permeabilization buffer and analyzed.  172 
Intracellular staining for VIP detection 173 
HESC cells were stimulated with different concentrations of P4 (10-5M, 10-6M and 10-7M) over 24 hours 174 
and incubated with Stop Golgi in the last 4 hours of culture following manufacturer’s instructions 175 
(Becton Dickinson, San José, CA), to promote intracellular accumulation. To assess VIP production, 176 
HESC cells recovered after TrypLE (Invitrogen) treatment were washed by PBS, fixed and 177 
permeabilized with the citofix/Perm kit (at manufacturer´s recommended concentrations, Becton 178 
Dickinson, San José, CA). After washing, permeabilized cells were incubated for 30 min with rabbit 179 
anti-VIP Ab (Peninsula-Bachem Inc, San Carlos, CA, USA) then washed and incubated with FITC-180 
conjugated anti-rabbit Ab (Santa Cruz, Palo Alto, CA). Cells were then washed with PBS-2% FCS to 181 
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allow membrane closure. Ten thousand events were acquired in a FACSAria II cytometer and results 182 
were analyzed using the WinMDI software. Negative control samples were incubated in parallel with 183 
an irrelevant, isotype-matched Ab. Results for positive cells are expressed as the mean intensity 184 
fluorescence (MIF) compared with the same cells cultured in complete media.  185 
Migration assays 186 
We evaluated the migration of the FOXP3+ cells using the different CM as stimuli obtained from HESC 187 
cells cultured in the presence P4, LPS, VIP or VIP-antagonist. An anti-RANTES neutralizing antibody 188 
(1 µg/ml, R&D System, MN, USA) was added during the assay to evaluate the chemokine role. After 189 
differentiation the naïve T cells were seeded in 8µm-inserts (4 x 10
4
 cells/insert) (BD Falcon cell culture 190 
inserts), which then were set in a 24-well plate containing the CM from HESC cells cultured under 191 
different conditions.  After 24 hours, the cells were recovered from the lower compartment and the 192 
frequency of FOXP3+ cells were quantified by FACS analysis. As a positive control, we used 20% 193 
human serum. The results are expressed as the folds of increase with respect to the positive control.  194 
Statistical analysis 195 
The significance of the results was analyzed by the Student´s  t-test and ANOVA with Bonferroni post 196 
test for parametric anlysis of HESC cell line-samples. Mann-Whitney U-test was used for the analysis 197 
of non-parametric samples from maternal PBMCs. We used the GraphPad Prism5 software (GraphPad, 198 
San Diego, CA) and a value of *p<0.05 was considered significant. 199 
 200 
RESULTS 201 
Endometrial stromal cells express VIP/VPAC system and progesterone modulates its expression 202 
First, we evaluated the expression of VIP and its receptors VPAC1 and VPAC2 in human 203 
endometrial stromal cells (HESC cell line). As depicted in Figure 1A, VIP and VPAC1 are 204 
constitutively expressed in stroma cells. Since progesterone (P4) has modulatory effects on 205 
endometrial cell differentiation and function at early pregnancy, we evaluated whether it affected 206 
VIP/VPAC system expression in HESC. For that purpose HESC cells were cultured at 70% of 207 
confluence in the absence or presence of P4 (10-6M) and we observed that P4 significantly increased 208 
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VIP expression in HESC cells while VPAC1 was not modulated as determined by RTqPCR (Figure 209 
1A). This result was confirmed by performing a progesterone concentration-response curve and 210 
determining median intensity fluorescence by flow cytometry, and we observed that P4 significanlty 211 
increased VIP intracellular production with a peak at 10
-6
M Figure 1B. The mean intensity 212 
fluorescence of VIP in HESC treated with different P4 concentrations is also shown as a 213 
representative histogram. VPAC2 expression was not detected in HESC cells under these conditions. 214 
 215 
VIP induces chemokine expression  216 
Our next objective was to determine the effect of VIP on the expression of chemokines 217 
involved in leukocyte recruitment toward endometrial stromal cells. In addition, we evaluated the 218 
effect of LPS as a proinflammatory stimulus. Hence, the expression of the chemokines RANTES 219 
(CCL5) involved in T cell recruitment, IL-8 (CXCL8) involved in neutrophils recruitment, and MCP-220 
1 (CCL2), one of the main chemokines involved in monocyte/macrophage recruitment were evaluated 221 
by RTqPCR in HESC cells stimulated or not with VIP (10-7M) and LPS (100 ng/ml).  As shown in 222 
figures 2A, B and C, LPS increased RANTES, IL-8 and MCP-1 expression. VIP by itself did not have 223 
a significant effect on cytokine production by HESCs; however, the combination of LPS and VIP 224 
further enhanced LPS-induced RANTES expression. 225 
 226 
Progesterone induces RANTES expression through a VIP pathway 227 
Since RANTES expression was further increased in the presence of VIP and LPS, and P4 228 
induced endogenous VIP production, we investigated whether RANTES expression was modulated 229 
by endogenous VIP on HESC cells. Therefore, HESC cells were cultured in the absence or presence 230 
of P4, LPS (100 ng/ml) and VIP-antagonist to evaluate the relevance of the endogenous VIP. We 231 
could observe that VIP-induced RANTES expression in the presence of LPS was prevented by VIP 232 
antagonist (Figure 3A). Progesterone also induced RANTES expression and this was far more 233 
pronounced in the presence of LPS.  VIP antagonist prevented the increase of RANTES expression 234 
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mediated by P4 and LPS, suggesting that RANTES induction involved a VIP-mediated pathway 235 
(Figure 3A). 236 
We then investigated the modulation of one transcription factor involved in RANTES 237 
expression as the Kruppel-Like Factor 13 (KLF13) (Song et al. 2002, Pabona et al. 2010).  HESC 238 
cells were cultured in the absence or presence of P4, VIP, LPS and VIP antagonist and then KLF13 239 
expression was evaluated by RTqPCR. As shown in Figure 3B, P4 and VIP in the presence of LPS 240 
significantly increased KLF13 expression. VIP antagonist prevented the increase of KLF13 241 
expression induced only by VIP and LPS.  242 
Endometrial stromal cells specifically recruit iTregs through RANTES production  243 
Our next step was to determine if HESC cells have the ability to attract iTregs.  Human Treg 244 
cells were differentiated from naïve CD45RA+CCR7+ cells obtained from fertile women PBMCs 245 
cultured with IL-2 and TGF-β over 5 days, as described in the Materials and Methods section. We 246 
then performed migration assays using a multi-chamber system. In vitro differentiated iTregs were 247 
seeded onto 8µm pore-inserts, allowing cell migration towards the CM used as a chemotactic stimulus 248 
in the lower compartment. After 24h cells were recovered from the lower compartment and FOXP3 249 
expression was quantified by FACS analysis. As depicted in figure 4A, the CM from HESC cells 250 
increased the frequency of FOXP3+ cells to levels similar to the migration observed in the presence of 251 
human serum (positive control). However, when the migration assay was performed in the presence of 252 
CM from HESC cells cultured in the presence of VIP antagonist, the recruitment of iTregs to the 253 
lower compartment was prevented (see Figure 4A). Moreover, addition of anti-RANTES neutralizing 254 
Ab to the CM from HESC treated with P4 and LPS also was able to prevent iTregs migration (see 255 
Figure 4A). Figure 4B shows representative dotplots with the percentage of FOXP3+ cells. We did 256 
not observe changes in the migration rate of the FOXP3 negative population under the same 257 
conditions mentioned above suggesting that RANTES participates in the specific recruitment of 258 
iTregs toward HESC cells (Figure 4C). 259 
 260 
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VIP induces decidualization of endometrial stromal cells 261 
On the hypothesis of a potential contribution of VIP to the decidualization program, we 262 
investigated VIP direct effects on endometrial stromal cells. Therefore, HESC cells were cultured in 263 
the absence or presence of VIP (10
-8
M to 10
-6
M) or in the presence of medroxyprogesterone-dibutyryl 264 
cAMP, as a positive control of decidualization, and after 8 days of culture we evaluated the 265 
expression of IGFBP-1 (Insulin-like growth factor-binding protein 1, also known as Placental Protein 266 
12), a decidualization marker. We observed that HESC cells cultured with 10
-7
M and 10
-6 
M VIP 267 
significantly increased IGFBP-1 expression (Figure 5A). The modulation in IGFBP-1 was 268 
accompained by morphological changes that characterize the decidualization process as depicted in 269 
Figure 5B.  270 
Since endometrial stromal cells after decidualization increased chemokine production and VIP 271 
induced the marker of decidualization IGFBP-1 on HESC cells, we wondered if VIP was also able to 272 
increase RANTES expression after cell differentiation. HESC cells were decidualized in the presence 273 
of VIP (10-6M to 10-8M) and after 8 days we observed a significant increase in RANTES expression 274 
(see Figure 5C). This increase was also accompanied by a significant increase in the expression of 275 
KLF13 in HESC cells, which is a RANTES transcription factor besides a decidualization marker (see 276 
Figure 5D). 277 
Taken together, these results suggest that VIP might participate in the decidualization process 278 
not only by the induction of decidualization markers, but also by increasing RANTES production, 279 
which mediates the recruitment of iTregs.  280 
 281 
DISCUSSION 282 
In humans, the decidualization process involves the transformation of stromal fibroblasts into 283 
epithelioid decidual cells and the recruitment of immune cells critical for decidual development in an 284 
early inflammatory microenvironment, thus, multiple regulatory mechanisms are required to maintain 285 
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the local immune homeostasis (Wilcox et al. 1999, Cahouat et al. 2010, Terness et al. 2007, Yoshinaga 286 
et al. 2010). 287 
In line with the strict regulation that Treg cells have in the control of the effector immune 288 
responses throughout pregnancy (Guerin et al. 2010, Robertson et al. 2009, Aluvihare et al. 2004, 289 
Ramhorst et al. 2012), we analyzed the contribution of the neuropeptide VIP to the decidualization 290 
program reflected by the increase of decidualization markers and by the recruitment of iTregs toward 291 
endometrial stromal cells as a local regulator of the implantatory inflammatory response. For that 292 
purpose, we used the HESC cell line cultured under different stimuli and iTregs differentiated from 293 
naïve CD45RA+CCR7+ obtained from fertile women’s PBMCs as an in vitro model of interaction. 294 
HESC cells were cultured in the presence of an effective concentration of P4 (10
-6
M), and LPS (100 295 
ng/ml) as an inflammatory stimulus that modulated chemokine production but did not affect cell 296 
viability (Abraham et al. 2004b).  297 
The results presented in this study suggest that the neuropeptide VIP, with potent anti-298 
inflammatory and immunomodulatory effects, could contribute to the decidualization process inducing 299 
endometrial stromal cell expression of decidualization markers and the selective recruitment of iTregs 300 
toward HESC cells by increasing RANTES production under the effect of progesterone in the presence 301 
of a inflammatory microenvironment.  302 
Our conclusions are based on several observations: First, HESC cells express VIP and its 303 
constitutive receptor VPAC1, and P4 has the ability to increase VIP production. Second, RANTES 304 
expression, one of the main chemokines involved in T cell recruitment was induced by VIP in the 305 
presence of LPS and its induction was mediated by P4. Finally, the migration assay of iTregs toward 306 
conditioned media from HESC cells revealed that the endogenous VIP production induced by P4 and 307 
LPS stimulation could selectively attract them through RANTES production, since the anti-RANTES 308 
neutralizing Ab or VIP antagonist prevented the iTregs migration.  309 
VIP might be one of the first  mediators that induces decidualization through its interaction 310 
with the VPAC1 receptor and triggering cAMP signaling in HESC cells to increase the expression of 311 
IGFBP-1 and KLF-13, both markers of decidualization accompained by morphological changes 312 
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characteristic of decidualized cells. In fact, KLF13 is not only a decidualization marker, also is a 313 
transcription factor that binds to RANTES-promoter, necessary to mediate RANTES transcription 314 
(Song et al. 2002). This mechanism could explain how endogenous VIP regulates RANTES 315 
expression on HESC cells thus contributing to the selective recruitment of iTregs that might allow the 316 
control of tissue damage during embryo implantation. In this sense, Nancy et al. (Nancy et al. 2012) 317 
recently reported that genes encoding chemokines are subject to epigenetic silencing in decidual 318 
stromal cells to restrain the attraction of Th1 and T cytotoxic profiles as a strategy to prevent potential 319 
tissue damage. In brief, the decidualization program involves many regulatory molecules that play 320 
functional roles, such as insulin-like growth factors, interleukin-1, 6, 10 and TGF-β families, the 321 
neuropeptide VIP, chemokines as RANTES with their receptors, and adhesion molecules that 322 
generate a network to control implantation processes such as trophoblast adhesion, invasion and the 323 
selective recruitment of maternal leukocyte subpopulations (Dimitriadis et al. 2000, Salomensen et al. 324 
1999, Terness et al. 2007, Yoshinaga et al. 2010, Fraccaroli et al. 2011). 325 
Interestingly, spontaneous decidualization of stromal cells occurs in the absence of pregnancy. It 326 
was proposed that cyclic endometrial decidualization followed by menstruation “preconditions“ uterine 327 
tissues for a hyperinflammatory response and oxidative stress that is in turn accompanied by deep 328 
trophoblast invasion during early pregnancy (Teklenburg et al. 2010a, Teklenburg et al. 2010b, 329 
Bronsens et al. 2009). Therefore, the ability of the human endometrium to generate an adequate 330 
decidual response based on successive inflammatory events might contribute to a sensitization of the 331 
uterine tissues. Under this hypothesis of repeated inflammatory events it is conceivable that a tight 332 
immune homeostatic control prior to implantation is required (Kim et al. 2009, Weiss et al. 2009). In 333 
this context the ability of HESC cells to selectively recruit iTregs might contribute to maintain immune 334 
homeostasis at early stages of implantation. 335 
Finally, even though the research in the past few years provided a better understanding of 336 
trophoblast-endometrial interactions during the initial stage of implantation by means of various human 337 
cell experimental approaches, the identification of biomarkers with clinical utility for patients with 338 
implantation failures is still open.   339 
Page 13 of 26
 14
 340 
Declaration of interest: Authors fully declare any financial or other potential conflict of interest. 341 
Funding: This study was supported by grants to RR (CONICET PIP 2659, 200034 from 342 
University of Buenos Aires) and to CPL (PICT 2011 0144 from ANPCyT).  343 
Authors' contributions: CPL and RR designed the study and wrote the manuscript. EG carried out 344 
all the experiments with HESC cells and decidualization, the differentiation of iTregs and  the co 345 
cultures, the migration assays. DP and MA helped with RT-PCRs data analyses and interpretation. 346 
GM supervised the study and discuss the results . All authors read and approved the final manuscript. 347 
348 
Page 14 of 26
 15
References  349 
Abrahams VM, Kim YM, Straszewski SL, Romero R & Mor G 2004a Macrophages and 350 
apoptotic cell clearance during pregnancy. American Journal of Reproductive 351 
Immunology (New York, N.Y.: 1989) 51 275–282. (doi:10.1111/j.1600-352 
0897.2004.00156.x) 353 
Abrahams VM, Bole-Aldo P, Kim YM, Straszewski-Chavez SL, Chaiworapongsa T, 354 
Romero R & Mor G 2004b Divergent trophoblast responses to bacterial products 355 
mediated by TLRs. Journal of Immunology (Baltimore, Md. : 1950) 173 4286–4296. 356 
Aluvihare VR, Kallikourdis M & Betz AG 2004 Regulatory T cells mediate maternal 357 
tolerance to the fetus. Nature Immunology 5 266–271. (doi:10.1038/ni1037) 358 
Bromley SK, Mempel TR & Luster AD 2008 Orchestrating the orchestrators: chemokines in 359 
control of T cell traffic. Nature Immunology 9 970–980. (doi:10.1038/ni.f.213) 360 
Brosens JJ, Parker MG, McIndoe A, Pijnenborg R & Brosens IA 2009 A role for 361 
menstruation in preconditioning the uterus for successful pregnancy. American Journal 362 
of Obstetrics and Gynecology 200 615.e1–6. (doi:10.1016/j.ajog.2008.11.037) 363 
Catalano RD, Critchley HO, Heikinheimo O, Baird DT, Hapangama D, Sherwin JRA, 364 
Charnock-Jones DS, Smith SK & Sharkey AM 2007 Mifepristone induced 365 
progesterone withdrawal reveals novel regulatory pathways in human endometrium. 366 
Molecular Human Reproduction 13 641–654. (doi:10.1093/molehr/gam021) 367 
Chaouat G, Petitbarat M, Dubanchet S, Rahmati M & Ledée N 2010 Tolerance to the foetal 368 
allograft? American Journal of Reproductive Immunology (New York, N.Y. : 1989) 63 369 
624–636. (doi:10.1111/j.1600-0897.2010.00832.x) 370 
Couvineau A & Laburthe M 2012 VPAC receptors: structure, molecular pharmacology and 371 
interaction with accessory proteins. British Journal of Pharmacology 166 42–50. 372 
(doi:10.1111/j.1476-5381.2011.01676.x) 373 
Dey SK, Lim H, Das SK, Reese J, Paria BC, Daikoku T & Wang H 2004 Molecular cues to 374 
implantation. Endocrine Reviews 25 341–373. (doi:10.1210/er.2003-0020) 375 
Dimitriadis E, Nie G, Hannan NJ, Paiva P & Salamonsen LA 2010 Local regulation of 376 
implantation at the human fetal-maternal interface. The International Journal of 377 
Developmental Biology 54 313–322. (doi:10.1387/ijdb.082772ed) 378 
Ekström J, Månsson B & Tobin G 1983 Vasoactive intestinal peptide evoked secretion of 379 
fluid and protein from rat salivary glands and the development of supersensitivity. Acta 380 
Physiologica Scandinavica 119 169–175. (doi:10.1111/j.1748-1716.1983.tb07322.x) 381 
Fraccaroli L, Alfieri J, Leiros CP & Ramhorst R 2009a Immunomodulatory effects of 382 
chemokines during the early implantation window. Frontiers in Bioscience (Elite 383 
Edition) 1 288–298. 384 
Page 15 of 26
 16
Fraccaroli L, Alfieri J, Larocca L, Calafat M, Mor G, Leirós CP & Ramhorst R 2009b A 385 
potential tolerogenic immune mechanism in a trophoblast cell line through the 386 
activation of chemokine-induced T cell death and regulatory T cell modulation. Human 387 
Reproduction (Oxford, England) 24 166–175. (doi:10.1093/humrep/den344) 388 
Fraccaroli L, Alfieri J, Larocca L, Calafat M, Roca V, Lombardi E, Ramhorst R & Leirós 389 
CP 2009c VIP modulates the pro-inflammatory maternal response, inducing tolerance 390 
to trophoblast cells. British Journal of Pharmacology 156 116–126. 391 
(doi:10.1111/j.1476-5381.2008.00055.x) 392 
Fraccaroli L, Grasso E, Zeitler E, Lombardi E, Gogorza S, Etchepareborda JJ, Nagle C, 393 
Cortelezzi M, Pérez Leirós C & Ramhorst R 2011 Modulation of maternal LIF 394 
producers T cells by trophoblast and paternal antigens. American Journal of 395 
Reproductive Immunology (New York, N.Y.: 1989) 65 133–145. (doi:10.1111/j.1600-396 
0897.2010.00890.x) 397 
Gellersen B & Brosens J 2003 Cyclic AMP and progesterone receptor cross-talk in human 398 
endometrium: a decidualizing affair. The Journal of Endocrinology 178 357–372. 399 
Gellersen B, Brosens IA & Brosens JJ 2007 Decidualization of the human endometrium: 400 
mechanisms, functions, and clinical perspectives. Seminars in Reproductive Medicine 401 
25 445–453. (doi:10.1055/s-2007-991042) 402 
Gomez-Lopez N, Guilbert LJ & Olson DM 2010 Invasion of the leukocytes into the fetal-403 
maternal interface during pregnancy. Journal of Leukocyte Biology 88 625–633. 404 
(doi:10.1189/jlb.1209796) 405 
Gonzalez-Rey E, Anderson P & Delgado M 2007 Emerging roles of vasoactive intestinal 406 
peptide: a new approach for autoimmune therapy. Annals of the Rheumatic Diseases 66 407 
Suppl 3 iii70–6. (doi:10.1136/ard.2007.078519) 408 
Guerin LR, Prins JR & Robertson S a 2009 Regulatory T-cells and immune tolerance in 409 
pregnancy: a new target for infertility treatment? Human Reproduction Update 15 517–410 
535. (doi:10.1093/humupd/dmp004) 411 
Kim MJ, Romero R, Kim CJ, Tarca AL, Chhauy S, LaJeunesse C, Lee D-C, Draghici S, 412 
Gotsch F, Kusanovic JP et al. 2009 Villitis of unknown etiology is associated with a 413 
distinct pattern of chemokine up-regulation in the feto-maternal and placental 414 
compartments: implications for conjoint maternal allograft rejection and maternal anti-415 
fetal graft-versus-host disease. Journal of Immunology (Baltimore, Md. : 1950) 182 416 
3919–3927. (doi:10.4049/jimmunol.0803834) 417 
King AE & Critchley HOD 2010 Oestrogen and progesterone regulation of inflammatory 418 
processes in the human endometrium. The Journal of Steroid Biochemistry and 419 
Molecular Biology 120 116–126. (doi:10.1016/j.jsbmb.2010.01.003) 420 
Krikun G, Mor G, Alvero A, Guller S, Schatz F, Sapi E, Rahman M, Caze R, Qumsiyeh M 421 
& Lockwood CJ 2004 A novel immortalized human endometrial stromal cell line with 422 
normal progestational response. Endocrinology 145 2291–2296. (doi:10.1210/en.2003-423 
1606) 424 
Page 16 of 26
 17
Leceta J, Gomariz RP, Martinez C, Carrión M, Arranz A & Juarranz Y 2007 Vasoactive 425 
intestinal peptide regulates Th17 function in autoimmune inflammation. 426 
Neuroimmunomodulation 14 134–138. (doi:10.1159/000110636) 427 
Mesiano S, Wang Y & Norwitz ER 2011 Progesterone receptors in the human pregnancy 428 
uterus: do they hold the key to birth timing? Reproductive Sciences (Thousand Oaks, 429 
Calif.) 18 6–19. (doi:10.1177/1933719110382922) 430 
Nancy P, Tagliani E, Tay C-S, Asp P, Levy DE & Erlebacher A 2012 Chemokine gene 431 
silencing in decidual stromal cells limits T cell access to the maternal-fetal interface. 432 
Science (New York, N.Y.) 336 1317–1321. (doi:10.1126/science.1220030) 433 
Pabona JMP, Zeng Z, Simmen F a & Simmen RCM 2010 Functional differentiation of 434 
uterine stromal cells involves cross-regulation between bone morphogenetic protein 2 435 
and Kruppel-like factor (KLF) family members KLF9 and KLF13. Endocrinology 151 436 
3396–3406. (doi:10.1210/en.2009-1370) 437 
Paria BC, Reese J, Das SK & Dey SK 2002 Deciphering the cross-talk of implantation: 438 
advances and challenges. Science (New York, N.Y.) 296 2185–2188. 439 
(doi:10.1126/science.1071601) 440 
Pérez Leirós C & Ramhorst R 2013 Tolerance induction at the early maternal-placental 441 
interface through selective cell recruitment and targeting by immune polypeptides. 442 
American Journal of Reproductive Immunology (New York, N.Y.: 1989) 69 359–368. 443 
(doi:10.1111/aji.12087) 444 
Ramhorst R, Patel R, Corigliano A, Etchepareborda JJ, Fainboim L & Schust D 2006 445 
Induction of maternal tolerance to fetal alloantigens by RANTES production. American 446 
Journal of Reproductive Immunology (New York, N.Y. : 1989) 56 302–311. 447 
(doi:10.1111/j.1600-0897.2006.00430.x) 448 
Ramhorst R, Gutiérrez G, Corigliano A, Junovich G & Fainboim L 2007 Implication of 449 
RANTES in the modulation of alloimmune response by progesterone during 450 
pregnancy. American Journal of Reproductive Immunology (New York, N.Y. : 1989) 451 
57 147–152. (doi:10.1111/j.1600-0897.2006.00458.x) 452 
Ramhorst R, Fraccaroli L, Aldo P, Alvero AB, Cardenas I, Leirós CP & Mor G 2012 453 
Modulation and recruitment of inducible regulatory T cells by first trimester 454 
trophoblast cells. American Journal of Reproductive Immunology (New York, N.Y. : 455 
1989) 67 17–27. (doi:10.1111/j.1600-0897.2011.01056.x) 456 
Robertson S a, Prins JR, Sharkey DJ & Moldenhauer LM 2013 Seminal fluid and the 457 
generation of regulatory T cells for embryo implantation. American Journal of 458 
Reproductive Immunology (New York, N.Y. : 1989) 69 315–330. 459 
(doi:10.1111/aji.12107) 460 
Salamonsen LA & Woolley DE 1999 Menstruation: induction by matrix metalloproteinases 461 
and inflammatory cells. Journal of Reproductive Immunology 44 1–27. 462 
Page 17 of 26
 18
Song A, Patel A, Thamatrakoln K, Liu C, Feng D, Clayberger C & Krensky AM 2002 463 
Functional domains and DNA-binding sequences of RFLAT-1/KLF13, a Krüppel-like 464 
transcription factor of activated T lymphocytes. The Journal of Biological Chemistry 465 
277 30055–30065. (doi:10.1074/jbc.M204278200) 466 
Spong CY, Lee SJ, McCune SK, Gibney G, Abebe DT, Alvero R, Brenneman DE & Hill 467 
JM 1999 Maternal regulation of embryonic growth: the role of vasoactive intestinal 468 
peptide. Endocrinology 140 917–924. (doi:10.1210/endo.140.2.6481) 469 
Stoikos CJ, Harrison CA, Salamonsen LA & Dimitriadis E 2008 A distinct cohort of the 470 
TGFbeta superfamily members expressed in human endometrium regulate 471 
decidualization. Human Reproduction (Oxford, England) 23 1447–1456. 472 
(doi:10.1093/humrep/den110) 473 
Teklenburg G, Salker M, Molokhia M, Lavery S, Trew G, Aojanepong T, Mardon HJ, 474 
Lokugamage AU, Rai R, Landles C et al. 2010a Natural selection of human embryos: 475 
decidualizing endometrial stromal cells serve as sensors of embryo quality upon 476 
implantation. PloS One 5 e10258. (doi:10.1371/journal.pone.0010258) 477 
Teklenburg G, Salker M, Heijnen C, Macklon NS & Brosens JJ 2010b The molecular basis 478 
of recurrent pregnancy loss: impaired natural embryo selection. Molecular Human 479 
Reproduction 16 886–895. (doi:10.1093/molehr/gaq079) 480 
Terness P, Kallikourdis M, Betz AG, Rabinovich GA, Saito S & Clark DA 2007 Tolerance 481 
signaling molecules and pregnancy: IDO, galectins, and the renaissance of regulatory T 482 
cells. American Journal of Reproductive Immunology (New York, N.Y.: 1989) 58 483 
238–254. (doi:10.1111/j.1600-0897.2007.00510.x) 484 
Van Voorhis BJ, Anderson DJ & Hill JA 1989 The effects of RU 486 on immune function 485 
and steroid-induced immunosuppression in vitro. The Journal of Clinical 486 
Endocrinology and Metabolism 69 1195–1199. (doi:10.1210/jcem-69-6-1195) 487 
Weiss G, Goldsmith LT, Taylor RN, Bellet D & Taylor HS 2009 Inflammation in 488 
reproductive disorders. Reproductive Sciences (Thousand Oaks, Calif.) 16 216–229. 489 
(doi:10.1177/1933719108330087) 490 
Wilcox AJ, Baird DD & Weinberg CR 1999 Time of implantation of the conceptus and loss 491 
of pregnancy. The New England Journal of Medicine 340 1796–1799. 492 
(doi:10.1056/NEJM199906103402304) 493 
Yoshinaga K 2010 Research on Blastocyst Implantation Essential Factors (BIEFs). 494 
American Journal of Reproductive Immunology (New York, N.Y. : 1989) 63 413–424. 495 
(doi:10.1111/j.1600-0897.2010.00853.x) 496 
 497 
Legends to Figures  498 
Figure 1: VIP/VPAC system on HESC cells. (A) HESC cells at 70% of confluence in a 24 well flat-499 
bottom plate were cultured in the absence or presence of P4 (10-6M). After 24 hours, HESC cells were 500 
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recovered and the expression of VIP and its receptors VPAC1 was evaluated by RTqPCR. Result shown 501 
is representative of five others run similarly and bars at the right side represent VIP and VPAC1 mean 502 
expression  relative to GAPDH ± S.E.M from 5 independent experiments (*p<0.05, Student t-test). (B): 503 
HESC cells also were cultured in the presence of P4 at different concentrations during 24 hours. 504 
Recovered cells were permeabilized and intracellularly stained with anti-VIP mAb. Results are 505 
expressed as the Mean Intensity Flourescence (MIF) and represent mean ± SEM of 3 independent 506 
experiments (*p<0.05, Student t-test). The right panel shows a representative histogram profile of one of 507 
3 similar experiments.  508 
 509 
Figure 2: Induction of chemokines by LPS and VIP. HESC cells at 70% of confluence in a 24 well 510 
flat-bottom plate, were cultured in the absence or presence of VIP (10-7M) and LPS (100 ng/ml). After 511 
24 hours, HESC cells were recovered and the expression of (A): RANTES (CCL5), (B): IL-8 (CXCL8) 512 
and (C): MCP-1 (CCL2) was evaluated byRTqPCR. Bars represent chemokine mean expression relative 513 
to GAPDH ± S.E.M  from 5 independent experiments (*p<0.05, Student t-test).  514 
 515 
Figure 3: Progesterone induced RANTES expression through a VIP pathway. HESC cells at 70% 516 
of confluence in a 24 well flat-bottom plate, were stimulated with different combinations of VIP (10-517 
7
M), P4 (10
-6
M), VIP-antagonist (ANT: 10
-5
M) and LPS (100 ng/ml). After 24 hours, HESC cells were 518 
recovered and the expression of RANTES (A) and KLF13 (B) were evaluated by RTqPCR. Bars 519 
represent RANTES or KLF13 mean expression relative to GAPDH ± S.E.M relativized to LPS stimuli 520 
from 6 independent experiments (*p<0.05, ANOVA, post test Bonferroni).  521 
 522 
Figure 4. Modulation of iTregs migration. The iTregs were differentiated in vitro obtained from 523 
CD4+ naïve T cells as described in Material and Methods. An 8µm transwell system was used for 524 
migration assay. The iTregs were seeded in the upper compartment and CM obtained from HESC cells 525 
under different stimuli (cultured in presence of VIP (10-7M), P4 (10-6M), VIP-antagonist (ANT: 10-5M) 526 
and LPS (100 ng/ml)) in the lower compartment in the presence or not of anti-RANTES (αRANTES) 527 
neutralizing antibody. The migration was evaluated by flow cytometry as total number of FOXP3+ 528 
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cells. (A)  The results are expressed as the folds of increase with respect to the positive control (AB 529 
human-serum) from 3 independent experiments using different maternal PBMCs (Mann Whitney test 530 
*p<0.05) and (B) shows representatives dot plots profile with the percentage of FOXP3+ cells.  531 
 532 
Figure 5: VIP induced decidualization of endometrial stromal cells. HESC cells were cultured in the 533 
absence or presence of VIP (10-6M to 10-8M) or in the presence of MPA-dibutyryl cAMP as positive 534 
control, and after 8 days of culture we evlauted the expression of IGFBP-1 (A), the morphologic 535 
changes after 24 days of cultured (B), the expression of RANTES (C) and KLF13 (D) by RTqPCR. 536 
Bars represent mean expression relative to GAPDH ± S.E.M from 3 independent experiments (*p<0.05, 537 
ANOVA, post test Bonferroni).  538 
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Table I: PCR primers 
Gene Primer (5’-3’) Product length Tm (˚C) 
VIP Fw TACAGGGCACCTTCTGCTCT 198 bp 57 
Rv CAAGAGTTTACTGAAGTCACT 
VPAC1 Fw CCCCTGGGTCAGTCTGGTG 100 bp 58 
Rv GAGACCTAGCATTCGCTGGTG 
VPAC2 Fw CCAGATGTCGGCGGCAACG 114 bp 56 
Rv GCTGATGGGAAACACGGCAAAC 
IL-8 Fw CCAACACAGAAATTATTGTAAAGC 163 bp 62 
Rv CACTGGCATCTTCACTGATTC 
MCP1 Fw CAGCAGCAAGTGTCCCAAAG 146 bp 64 
Rv GAGTGAGTGTTCAAGTCTTCGG 
RANTES Fw TGCTGCTTTGCCTACATTGC 95 bp 64 
Rv AAGACGACTGCTGGGTTGG 
KLF13 Fw TTCGGTGGTTCCTTGGTGACTGG 169 bp 61 
Rv TGGACCCTTGGATTCTGCCTTGG 
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